Related literature
For general background to and pharmacological properties of Raltegravir, see: Burger (2010) ; Cocohoba & Dong (2008) ; Croxtall & Keam (2009) ; Evering & Markowitz (2008) ; Hicks & Gulick (2009); Savarino (2006) ; Temesgen & Siraj (2008) . For related structures, see : Fun et al. (2011); Shang et al. (2012) ; ; Shang, Qi et al. (2011); Thiruvalluvar et al. (2007) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Raltegravir (systematic name:5-hydroxy-1-methyl-2-{1-methyl-1- [(5-methyl-[1,3,4] oxadiazole-2-carbonyl)amino]-ethyl}-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid 4-fluorobenzylamide) monohydrate is the first in a novel class of HIV-1 integrase strand-transfer inhibitors with potent antiretroviral activity (Savarino, 2006; Hicks & Gulick, 2009; Evering & Markowitz, 2008; Temesgen & Siraj, 2008) . It inhibits the action of the HIV-1-specific enzyme that is responsible for the insertion of viral complimentary DNA into the host genome (Croxtall & Keam, 2009) . It is also found to be a generally well tolerated antiretroviral agent that may play an important role in the treatment of patients harboring resistance to other antiretroviral drugs (Cocohoba & Dong, 2008) . A review of the pharmacokinetics, pharmacology and clinical studies of Raltegravir has been published (Burger, 2010) . The crystal structures of some related compounds, viz., (Thiruvalluvar et al., 2007) , methyl 2-[2-(benzyloxycarbonylamino)propan-2-yl]-5-hydroxy-6-methoxypyrimidine-4-carboxylate (Fun et al., 2011) , methyl 2-(2-{[(benzyloxy)carbonyl]-amino}propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate , methyl 2-(2-{[(benzyloxy)carbonyl]amino}propan-2-yl)-5-hydroxy-6-methoxypyrimidine-4-carboxylate (Shang, Qi et al., 2011) and methyl 2-[2-(benzyloxycarbonylamino)propan-2-yl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydro pyrimidine-4-carboxylate (Shang et al., 2012) have been reported. In view of the importance of Raltegravir, this paper reports the crystal structure of (I), C 20 H 21 FN 6 O 5 . H 2 O.
In the title compound, (I), the dihedral angles between the mean planes of the pyrimidine ring and the phenyl and oxadiazole rings are 72.0 (1)° and 61.8 (3)° respectively (Fig. 1) . The mean plane of the oxadiazole ring is twisted by 15.63° from that of the phenyl ring. In addition, the mean plane of the N1-C14-O2 amide group adjacent to the oxadiazole ring is twisted by 18.8 (3)° from the mean plane of the oxidiazole ring. Bond lengths are within normal ranges (Allen et al., 1987) . Intramolecular O-H···O and C-H···N hydrogen bonds are observed in the molecule (Table. 1 ).
The crystal packing is stabilized by intermolecular O-H···O hydrogen bonds which include bifurcated O1W-H1WA···O3 and O1W-H1WA···O4 hydrogen bonds from the H1WA atom of the water molecule. In addition, intermolecular N1-H1···O5 and N4-H4A···O1W hydrogen bonds involving the two amide groups are also observed.
These interactions link the molecules into chains along [0 1 0].
Raltegravir (CAS No. 518048-05-0) (0.2 g) was dissolved in a 1:1:1(v/v) mixture of methanol, dimethyl sulfoxide and dimethyl formamide at 308 K and left for slow evaporation. Crystals suitable for X-ray work were obtained after a few months (m.p.: 383-388 K).
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Refinement
H1WA and H1WB were located in a difference map and refined isotropically. All other H atoms were placed in their calculated positions and then refined using a riding model with Atom-H lengths of 0.95Å (CH), 0.99Å (CH 2 ), 0.98Å (CH 3 ), 0.88Å (NH) or 0.84Å (OH). Isotropic displacement parameters for these atoms were set to 1.2 (CH, CH 2 , NH) or 1.5 (CH 3 , OH, OH 2 ) times U eq of the parent atom. Idealised Me and tetrahedral OH (O4(H4))were refined as rotating groups. The highest peak (-0.783) in the final difference map is located 1.02 Å from O1.
Computing details
Data collection: CrysAlis PRO (Agilent, 2012 ); cell refinement: CrysAlis PRO (Agilent, 2012) Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Symmetry codes: (i) −x+2, −y, −z+1; (ii) −x+2, −y+1, −z+1; (iii) −x+2, −y, −z+2; (iv) −x+1, −y, −z+1; (v) −x+1, −y, −z; (vi) x, y+1, z.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

